RxElite, Inc.
RXEI · OTC
12/31/2007 | 9/30/2006 | 9/30/2005 | 9/30/2004 | |
|---|---|---|---|---|
| Market Cap | $44 | $7 | $7 | $0 |
| - Cash | $10,114 | $63 | $3 | $0 |
| + Debt | $590 | $0 | $0 | $0 |
| Enterprise Value | -$9,480 | -$56 | $4 | $0 |
| Revenue | $2,812 | $1,177 | $966 | $835 |
| % Growth | 139% | 21.7% | 15.7% | – |
| Gross Profit | $144 | $742 | $517 | $835 |
| % Margin | 5.1% | 63.1% | 53.5% | 100% |
| EBITDA | -$16,465 | $158 | -$29 | $835 |
| % Margin | -585.6% | 13.4% | -3% | 100% |
| Net Income | -$17,165 | $94 | -$36 | -$34 |
| % Margin | -610.5% | 8% | -3.7% | -4.1% |
| EPS Diluted | -0.27 | 0.009 | -0.004 | 0 |
| % Growth | -3,100% | 350% | – | – |
| Operating Cash Flow | -$13,366 | $72 | $13 | – |
| Capital Expenditures | -$1,847 | -$12 | -$45 | – |
| Free Cash Flow | -$15,213 | $60 | -$31 | – |